IRIS
FUSCO, FERDINANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 6.172
NA - Nord America 4.926
EU - Europa 4.237
SA - Sud America 838
AF - Africa 186
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.681
SG - Singapore 2.847
RU - Federazione Russa 1.938
VN - Vietnam 1.193
CN - Cina 1.027
IT - Italia 873
BR - Brasile 695
HK - Hong Kong 507
FR - Francia 270
DE - Germania 218
FI - Finlandia 201
NL - Olanda 192
CA - Canada 147
UA - Ucraina 135
GB - Regno Unito 117
JP - Giappone 104
SE - Svezia 84
IN - India 78
IE - Irlanda 76
AR - Argentina 62
BD - Bangladesh 61
MX - Messico 56
ZA - Sudafrica 52
IQ - Iraq 49
CI - Costa d'Avorio 45
PH - Filippine 37
ID - Indonesia 36
TR - Turchia 35
TH - Thailandia 32
EC - Ecuador 30
PL - Polonia 25
ES - Italia 23
KR - Corea 18
TW - Taiwan 18
MA - Marocco 17
JO - Giordania 14
UZ - Uzbekistan 14
EG - Egitto 13
IR - Iran 13
PK - Pakistan 13
KE - Kenya 12
PY - Paraguay 11
CH - Svizzera 10
CO - Colombia 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
RS - Serbia 9
VE - Venezuela 9
AT - Austria 8
BE - Belgio 8
ET - Etiopia 8
MY - Malesia 8
RO - Romania 8
AZ - Azerbaigian 7
JM - Giamaica 7
NG - Nigeria 7
LT - Lituania 6
PE - Perù 6
AL - Albania 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
IL - Israele 5
KZ - Kazakistan 5
LB - Libano 5
NI - Nicaragua 5
DK - Danimarca 4
DZ - Algeria 4
GA - Gabon 4
GT - Guatemala 4
HU - Ungheria 4
KG - Kirghizistan 4
NP - Nepal 4
SN - Senegal 4
UY - Uruguay 4
BB - Barbados 3
DM - Dominica 3
GD - Grenada 3
NZ - Nuova Zelanda 3
OM - Oman 3
PS - Palestinian Territory 3
TN - Tunisia 3
AM - Armenia 2
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
BJ - Benin 2
DJ - Gibuti 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
KH - Cambogia 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
NC - Nuova Caledonia 2
PA - Panama 2
PF - Polinesia Francese 2
VC - Saint Vincent e Grenadine 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 16.336
Salva come PNG Salva come JPEG
Città #
Singapore 1.189
San Jose 662
Hong Kong 484
Moscow 466
Ho Chi Minh City 353
Ashburn 341
Chandler 308
Beijing 289
Hanoi 247
Millbury 207
Princeton 177
Amsterdam 172
Lauterbourg 167
The Dalles 155
Los Angeles 154
Santa Clara 147
Nanjing 138
Naples 135
Boston 121
Napoli 113
Tokyo 86
Buffalo 77
Munich 75
New York 72
Dallas 66
São Paulo 65
Wilmington 61
Ottawa 59
Da Nang 54
Jacksonville 53
Redondo Beach 52
Frankfurt am Main 46
Seattle 44
Des Moines 41
Nanchang 40
Hefei 38
Haiphong 37
Augusta 35
Shenyang 35
Denver 32
Orem 32
Milan 31
Norwalk 31
Hebei 29
Turku 28
Chicago 27
Montreal 27
Abidjan 25
Mexico City 25
Rome 25
Stockholm 25
Boardman 24
Dong Ket 24
Houston 24
Toronto 24
Ann Arbor 23
Atlanta 23
Brooklyn 23
Council Bluffs 23
Falls Church 23
Tianjin 23
Biên Hòa 22
Chennai 22
Warsaw 21
Johannesburg 19
London 19
Poplar 19
Baghdad 18
Can Tho 18
Jiaxing 17
Manchester 17
Bangkok 16
Bologna 16
Phoenix 16
Changsha 15
Rio de Janeiro 15
Hải Dương 14
San Francisco 14
Ankara 13
Belo Horizonte 13
Lawrence 13
Cambridge 12
Curitiba 12
Redwood City 12
Thái Bình 12
Goiânia 11
Jakarta 11
Nairobi 11
Shanghai 11
Tashkent 11
Thái Nguyên 11
Amman 10
Guayaquil 10
Nha Trang 10
Ninh Bình 10
Zola Predosa 10
Brasília 9
Bình Phước 9
Guangzhou 9
Mumbai 9
Totale 8.169
Salva come PNG Salva come JPEG
Nome #
Colonvaginoplastica versus ileovaginoplastica nel transessualismo andro-ginoide: studio di confronto.” 221
Perceptions, Expectations, Preferences, and Attitudes Toward Premature Ejaculation, Its Diagnosis and Topical Treatment with Fortacin™ Spray: Results from an Expert Panel Discussion 198
CISTECTOMIA RADICALE CON NEOVESCICA ORTOTOPICA IN PAZIENTI CON LAVARIANTE NESTED DEL CARCINOMA UROTELIALE: NOSTRA ESPERIENZA CLINICACON FOLLOW-UP DI 36 MESI. 190
A report from a single institute's 14-year experience in treatment of male-to-female transsexuals. 174
Diagnostic accuracy of three tesla biparametric magnetic resonance imaging of the prostate, prostate specific antigen density and their combination for the detection of clinically significant prostate cancer: Results from a retrospective study 163
Sildenafil effect on the human bladder involves the L-cysteine/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors 162
Does physical activity regulate prostate carcinogenesis and prostate cancer outcomes? A narrative review 155
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 153
Ejaculatory abstinence influences intravaginal ejaculatory latency time: Results from a prospective randomized trial 151
Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different? 147
SPHINGOSINE-1PHOSPHATE INDUCES ENDOTHELIAL NOS ACTIVATION THROUGH PHOSPHORYLATION IN HUMAN CORPUS CAVERNOSUM 143
Donor and Recipient Outcomes following Robotic-Assisted Laparoscopic Living Donor Nephrectomy: A Systematic Review 143
Urothelium muscarinic activation phosphorylates CBS Ser227 via cGMP/PKG pathway causing human bladder relaxation through H 2 S production 142
Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy 138
Hyperbaric Oxygen Therapy reduces mortality in patients with Fournier's gangrene. Results from a multi-institutional observational study 136
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation. 135
Vaginoplastica con flap penoscrotale nel transessualismo andro-ginoide 135
A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition. 135
Erectile dysfunction after surgical treatment. 134
Could YouTubeTM encourage men on prostate checks? A contemporary analysis 133
Correlation between detrusor collagen content and urinary symptoms in patients with prostatic obstruction 133
A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. 130
Female sexual dysfunction: an update on physiopathology. 130
A new era in the treatment of erectile dysfunction: chronic phosphodiesterase type 5 inhibition 130
Clinical Efficacy of Silodosin in Patients with Severe Lower Urinary Tract Symptoms Related to Benign Prostatic Obstruction: A Pooled Analysis of Phase 3 and 4 Trials 130
Androgens and morphologic remodeling at penile and cardiovascular levels: a common piece in complicated puzzles? 128
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy. 126
the detrusor muscle: an innocent victim of bladder outlet obstruction 124
Tamsulosin plus a new complementary and alternative medicine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a retrospective comparative study 123
A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease 121
A case of highly aggressive anaplastic seminoma of the testis presenting as fungating scrotal lesion 121
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation 120
Detection of Extraprostatic Extension of Cancer on Biparametric MRI Combining Texture Analysis and Machine Learning: Preliminary Results 117
Renal Transplantation Does Not Improve Erectile Function in Hemodialysed Patients. 116
UROTENSIN II AS A POSSIBLE SERUM MARKER OF ERECTILE DYSFUNCTION 116
Biparametric 3T Magentic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2? 116
Incidentally discovered pelvic paraganglioma: A case report 115
An ex vivo standardized assay to measure human platelet cGMP 114
Erectile dysfunction in patients with chronic viral hepatitis: a systematic review of the literature 114
A rare case of male pelvic squamous cell carcinoma of unknown primary origin presenting as perineal abscess and urethral stenosis 113
Endoscopic Spatulation of the Intramural Ureter: A Technique to Prevent Stenosis of the Ureterovesical Junction in Patients Undergoing Resection of the Ureteral Orifice 113
Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections. 112
Efficacy and safety of ciprofloxacin XR 1000 mg once daily versus ciprofloxacin 500 mg twice daily in the treatment of complicated urinary tract infections 111
Periprostatic nerve block (PNB) alone vs PNB combined with an anaesthetic-myorelaxant agent cream for prostate biopsy: a prospective, randomized double-arm study. 110
Endogenous urotensin–II induced-penile erection trhough eNOS phosphorylation in human corpus cavernosum 105
Involvement of L-cysteine/H2S pathway in human bladder homeostasis 103
Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study 103
Erectile dysfunction after surgical treatment. 102
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation 101
Female sexual dysfunction: an update on physiopathology. 101
LA DISFUNZIONE ERETTILE (DE) NEL PAZIENTE EMODIALIZZATO PRIMA EDOPO IL TRAPIANTO RENALE 100
VAGINOPLASTICA CON FLAP PENOSCROTALE NEL TRANSESSUALISMO ANDRO-GINOIDE 100
Flexible-dose vardenafil in a community-based population of men affected by erectile dysfunction: a 12-week open-label, multicenter trial 100
"A new validated questionnaire in the clinical evaluation of female sexual dysfunction (FSDQ): an Italian proposal" 100
Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica 100
Dapoxetine treatment in patients with lifelong premature ejaculation: The reasons of a "waterloo" 100
Benign Prostatic Obstruction Relief in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Enlargement Undergoing Endoscopic Surgical Procedures or Therapy with Alpha-Blockers: A Review of Urodynamic Studies 100
Detrusor overactivity and underactivity: implication for lower urinary tract symptoms related to benign prostate hyperplasia diagnosis and treatment 99
TADALAFIL ONCE DAILY AND EXTRACORPOREAL SHOCK WAVE THERAPY IN THE MANAGEMENT OF PATIENTS WITH PEYRONIE'S DISEASE AND ERECTILE DYSFUNCTION. RESULTS FROM A PROSPECTIVE RANDOMIZED TRIAL 99
Female sexual dysfunction: an update on physiopathology. ( Review ) 99
The detrusor muscle: an innocent victim of bladder outlet obstruction. 98
Invovement of beta-3-adrenergic receptor activation via Cyclic GMP-but not No-dependent mechanism in human corpus cavernosum function. 97
QUALITà DELLA VITA SESSUALE E SODDISFAZIONE DEL PAZIENTE DOPO CHIRURGIA PENIS-SPARING PER LESIONI PENIENE BENIGNE, PREMALIGNE O MALIGNE 97
Erectile dysfunction after surgical treatment. 96
Trattamento del Late onset Hypogonadism con testosterone in Gel: dati clinici di efficacia e sicurezza 96
Female sexual dysfunction: an update on physiopathology. 94
Phase Ii Multicentric Study of Sunitinib In Metastatic Renal Cell Carcinoma (mrcc) With A Poor Prognosis Refractory To Immunotherapy 94
Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: Still many gaps 94
Transperineal repair of a persistent rectourethral fistula using aporcine dermal graft 93
Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica 92
Neurophysiologic evaluation of central-peripheral sensory and motor pudendal pathways in primary premature ejaculation 91
Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans 90
Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study. 89
LA DISFUNZIONE ERETTILE (DE) NEL PAZIENTE EMODIALIZZATO PRIMA E DOPO IL TRAPIANTO RENALE 89
Endogenous urotensin II selectively modulates erectile function through eNOS 89
ERYTHEMATOUS ERUPTION WITH LINEAR VESCICULATION AND EOSINOPHILIA AT BIRTH 89
Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie's disease and erectile dysfunction: Results from a prospective randomized trial 89
Female sexual dysfunction: an update on physiopathology 88
The Role of the Hydrogen Sulfide Pathway in Male and Female Urogenital System in Health and Disease 88
IL PROFILO SOCIO-CULTURALE E CLINICO DEI TRANSESSUALI ANDRO-GINOIDIIN ITALIA: REPORT SULLA NOSTRA ESPERIENZA DI 14 ANNI NEL TRATTAMENTODEI DISORDINI DI IDENTITÀ DI GENERE 87
Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function. 87
A standardized procedure for using human corpus cavernosum stripa to evaluate drug activity and the role of mediators in Erectile Dysfunctions 87
The impact of non-urologic drugs on sexual function in men. 87
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy. 86
Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy. 85
PROSTATECTOMIA RADICALE PERINEALE VS PROSTATECTOMIA RADICALERETROPUBICA IN PAZIENTI PRECEDENTEMENTE SOTTOPOSTI A CHIRURGIAPROSTATICA: RISULTATI CHIRURGICI E FUNZIONALI 85
Colonvaginoplastica versus ileovaginoplastica 85
BPH/LUTS and ED: Common Pharmacological Pathways for a Common Treatment 84
EFFICACY AND SAFETY OF CIPROFLOXACIN XR 1000 MG ONCE DAILY VERSUS CIPROFLOXACIN 500 MG TWICE DAILY IN THE TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS 83
STUDIO PROSPETTICO RANDOMIZZATO, DOPPIO CIECO, PLACEBO CONTROLLATO VOLTO A VALUTAREL’EFFICACIA DELL ESWT NEL TRATTAMENTO DELLA MALATTIA DI LA PEYRONIE 82
L'IDROGENO SOLFORATO COME NUOVO MEDIATORE DELL'EREZIONE PENIENA NELL'UOMO 82
Androgens and benign prostatic hyperplasia 82
Did men with erectile dysfunction discuss their condition with partner and physicians? A survey of men attending a free call information service. 81
“Neurophysiological evaluation in primary premature ejaculation patients: our experience” 81
PROSTATECTOMIA RADICALE PERINEALE VS PROSTATECTOMIA RADICALE RETROPUBICA INPAZIENTI PRECEDENTEMENTE SOTTOPOSTI A CHIRURGIA PROSTATICA: RISULTATI CHIRURGICI EFUNZIONALI 80
A new biopsy technique to investigate Peyronie's disease associated histologic alterations: Results with two different forms of therapy 80
Human Cystathionine-β-Synthase Phosphorylation on Serine227 Modulates Hydrogen Sulfide Production in Human Urothelium 80
Attività miorilassante periferica della apomorfina e di un agonista selettivo del recettore D1 sul tessuto cavernoso umano 79
Nuova tecnica di biopsia di placca nella malattia di La Peyronie 78
Alpha-1 adrenergic antagonists, 5-alpha reductase inhibitors, phosphodiesterase type 5 inhibitors, and phytotherapic compounds in men with lower urinary tract symptoms suggestive of benign prostatic obstruction: A systematic review and meta-analysis of ur 74
Totale 11.071
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.250
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 0 0 38
2021/2022960 20 7 15 10 6 19 12 34 87 152 131 467
2022/2023942 205 59 15 62 98 79 6 77 120 169 41 11
2023/2024693 26 77 157 33 44 42 16 51 7 20 153 67
2024/20254.305 283 320 14 84 33 99 394 232 551 457 1.451 387
2025/20267.849 967 528 761 704 1.316 409 844 525 973 579 190 53
Totale 16.647